AbbVie repeatedly hiked Humira, Imbruvica prices and abused patents to keep competitors at bay: report
24 May 2021

https://www.fiercepharma.com/pharma/abbvie-repeatedly-raised-prices-for-humira-imbruvica-and-abused-u-s-patent-system-to-extend

 

AbbVie repeatedly hiked Humira, Imbruvica prices and abused patents to keep competitors at bay: report